HAT1 Citations (4)
Originally described in: Structural Genomics Consortium ClonesUnpublished
Articles Citing HAT1
Articles |
---|
Bisubstrate inhibitors to target histone acetyltransferase 1. Ngo L, Brown T, Zheng YG. Chem Biol Drug Des. 2019 May;93(5):865-873. doi: 10.1111/cbdd.13476. Epub 2019 Jan 30. PubMed |
Identification of lysine isobutyrylation as a new histone modification mark. Zhu Z, Han Z, Halabelian L, Yang X, Ding J, Zhang N, Ngo L, Song J, Zeng H, He M, Zhao Y, Arrowsmith CH, Luo M, Bartlett MG, Zheng YG. Nucleic Acids Res. 2021 Jan 11;49(1):177-189. doi: 10.1093/nar/gkaa1176. PubMed |
Histone lysine methacrylation is a dynamic post-translational modification regulated by HAT1 and SIRT2. Delaney K, Tan M, Zhu Z, Gao J, Dai L, Kim S, Ding J, He M, Halabelian L, Yang L, Nagarajan P, Parthun MR, Lee S, Khochbin S, Zheng YG, Zhao Y. Cell Discov. 2021 Dec 28;7(1):122. doi: 10.1038/s41421-021-00344-4. PubMed |
Chemoproteomic Profiling of Protein Substrates of a Major Lysine Acetyltransferase in the Native Cellular Context. Song J, Ngo L, Bell K, Zheng YG. ACS Chem Biol. 2022 May 20;17(5):1092-1102. doi: 10.1021/acschembio.1c00935. Epub 2022 Apr 13. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.